These specialized liposomes are designed to target CDH1, also known as E-cadherin, a protein commonly expressed on the surface of melanoma cells. By selectively binding to this molecule, the liposomes can enhance the precision of drug delivery, ensuring that the therapeutic agents are concentrated where they are most needed, thereby increasing their effectiveness. Furthermore, by interfering with cell adhesion signaling pathways, these liposomes may disrupt the tumor's ability to invade surrounding tissues, potentially leading to reduced metastasis and improved patient outcomes.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-1406CL | Anti-Human CDH1 Recombinant Antibody (SC10.19) | ELISA | |
TAB-1407CL | Anti-Human CDH1 Recombinant Antibody (SC10.6) | ELISA | |
TAB-1408CL | Anti-Human CDH1 Recombinant Antibody (SC10.178) | Cyt, FuncS | |
TAB-1409CL | Anti-Human CDH1 Recombinant Antibody (SC10.15) | ELISA | |
TAB-1410CL | Anti-Human CDH1 Recombinant Antibody (SC10.17) | Inhib |
There are currently no Customer reviews or questions for VS-1024-FY171. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.